100 related articles for article (PubMed ID: 25888357)
1. Effects of varying serum glucose levels on 18F-FDG biodistribution.
Webb RL; Landau E; Klein D; DiPoce J; Volkin D; Belman J; Voutsinas N; Brenner A
Nucl Med Commun; 2015 Jul; 36(7):717-21. PubMed ID: 25888357
[TBL] [Abstract][Full Text] [Related]
2. Influence of subcutaneous administration of rapid-acting insulin in the quality of (18)F-FDG PET/CT studies.
Garcia JR; Sanchis A; Juan J; Tomas J; Domenech A; Soler M; Moragas M; Riera E
Nucl Med Commun; 2014 May; 35(5):459-65. PubMed ID: 24535382
[TBL] [Abstract][Full Text] [Related]
3. The combined effects of serum lipids, BMI, and fatty liver on 18F-FDG uptake in the liver in a large population from China: an 18F-FDG-PET/CT study.
Liu G; Li Y; Hu P; Cheng D; Shi H
Nucl Med Commun; 2015 Jul; 36(7):709-16. PubMed ID: 25757200
[TBL] [Abstract][Full Text] [Related]
4. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT.
Büsing KA; Schönberg SO; Brade J; Wasser K
Nucl Med Biol; 2013 Feb; 40(2):206-13. PubMed ID: 23228852
[TBL] [Abstract][Full Text] [Related]
5. Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
Trägårdh M; Møller N; Sørensen M
J Nucl Med; 2015 Sep; 56(9):1366-71. PubMed ID: 26159590
[TBL] [Abstract][Full Text] [Related]
6. [Variations of the hepatic SUV in relation to the body mass index in whole body PET-CT studies].
Batallés SM; Villavicencio RL; Quaranta A; Burgos L; Trezzo S; Staffieri R; Pezzotto SM
Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):26-32. PubMed ID: 23177341
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyperglycemia on brain and liver
Viglianti BL; Wong KK; Wimer SM; Parameswaran A; Nan B; Ky C; Townsend DM; Rubello D; Frey KA; Gross MD
Biomed Pharmacother; 2017 Apr; 88():1038-1045. PubMed ID: 28192877
[TBL] [Abstract][Full Text] [Related]
8. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A
J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
[TBL] [Abstract][Full Text] [Related]
9. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
10. Impact of animal handling on the results of 18F-FDG PET studies in mice.
Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
[TBL] [Abstract][Full Text] [Related]
11. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
12. Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients.
Roy FN; Beaulieu S; Boucher L; Bourdeau I; Cohade C
J Nucl Med; 2009 Feb; 50(2):178-83. PubMed ID: 19164226
[TBL] [Abstract][Full Text] [Related]
13. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
Moon SH; Kim HS; Hyun SH; Choi YS; Zo JI; Shim YM; Lee KH; Kim BT; Choi JY
J Nucl Med; 2014 May; 55(5):743-8. PubMed ID: 24700884
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of (18)F-FDG in the liver in hepatic steatosis.
Keramida G; Potts J; Bush J; Verma S; Dizdarevic S; Peters AM
AJR Am J Roentgenol; 2014 Sep; 203(3):643-8. PubMed ID: 25148170
[TBL] [Abstract][Full Text] [Related]
15. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M
Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for N2 metastasis in patients with non-small-cell lung cancer: multivariate analyses of 18F-FDG PET/CT data.
Su M; Li Y; Li F; Li L; Tian R
Nucl Med Commun; 2014 Sep; 35(9):916-21. PubMed ID: 24785010
[TBL] [Abstract][Full Text] [Related]
17. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
Walter F; Federman N; Apichairuk W; Nelson S; Phelps ME; Allen-Auerbach M; Walter MA; Czernin J
Pediatr Hematol Oncol; 2011 Oct; 28(7):579-87. PubMed ID: 21936620
[TBL] [Abstract][Full Text] [Related]
18. Normal uptake of 18F-FDG in the testis: an assessment by PET/CT.
Kitajima K; Nakamoto Y; Senda M; Onishi Y; Okizuka H; Sugimura K
Ann Nucl Med; 2007 Sep; 21(7):405-10. PubMed ID: 17876554
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
[TBL] [Abstract][Full Text] [Related]
20. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans.
Kanstrup IL; Klausen TL; Bojsen-Møller J; Magnusson P; Zerahn B
Clin Physiol Funct Imaging; 2009 Apr; 29(2):108-13. PubMed ID: 19076727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
